METTL3 Suppresses Pancreatic Ductal Adenocarcinoma Progression through Activating Endogenous dsRNA-Induced Anti-Tumor Immunity

The authors demonstrated that METTL3, the key regulator of N6-methyladenosine modification, was downregulated in PDAC, and negatively correlated with PDAC malignant features.